Recent evidence relating to the impact of COVID-19 on people with diabetes is limited but
continues to emerge. COVID-19 pneumonia is a newly identified illness spreading rapidly …

Aims/hypothesis To provide a systematic overview of the current body of evidence on high-
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …

Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and
prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values …

Background Impaired respiratory function remains underrecognized in patients with type 2
diabetes (T2D), despite common pulmonary impairment. Meanwhile, there is little data …

Background Historically, a critical aetiological agent of health concern stays till eternity after
its discovery, so shall it be with the COVID‐19 outbreak. It has transformed human life to a …

Viruses have been present during all evolutionary steps on earth and have had a major
effect on human history. Viral infections are still among the leading causes of death. Another …

Metabolic disorders such as obesity, type 2 diabetes mellitus (T2DM), dyslipidemia, and non-
alcoholic fatty liver disease (NAFLD)–henceforth named metabolic dysfunction-associated …

Introduction Type 2 diabetes mellitus (T2DM) is a relevant risk factor for severe forms of
COVID-19 (SARS coronavrus 2 [SARS-CoV-2] disease 2019), and calls for caution because …

Type 2 diabetes mellitus (T2DM) is a widespread metabolic condition with a high global
morbidity and mortality rate that affects the whole body. Their primary consequences are …

Purpose: It has been reported that dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like
peptide-1 receptor agonists (GLP-1 RA), and sodium-glucose cotransporter-2 inhibitors …